Reliable partner for your next business venture
30 YEARS OF EXPERIENCE
CONVENIENTLY LOCATED IN THE CENTER OF EU
READY-TO-USE BIOSIMILARS
RELIABLE GMP SERVICES
Main areas of activities:
Analytical and EU GMP related services: contract-based batch release testing and EU QP batch release
Development activities: technologies development and tech transfer (biologicals, biosimilars API, generic final drug product)
Final Products:
FemmeFuture (with proBVformula)– in house developed patented protein-based gynecological products for the treatment of bacterial vaginosis, offered as intimate wash and vaginal ovules
Melatonin drug product– eCTD dossier and supply of final product
- Founded in 2007 by leading scientists from Sicor Biotech (TEVA Pharmaceuticals) who led CMC development of one of the first biosimilars in the EU
- Portfolio of 6 cost-efficient biosimilar technologies offered for out-licensing
- 1 technology already out-licensed for certain markets!
- Pipeline of 4 biobetter technologies developed using patented ProMER™ platform, that allows extending biopharmaceuticals’ circulation half-life in plasma
- EU cGMP certification for batch release and analytical testing
- Access to cGMP manufacturing to supply clinical and commercial needs
- In-depth know-how in: high-yield expression system development, easy-to-handle up-stream and down-stream process development, formulation development and comparability studies